| Primary |
| Hypertension |
63.0% |
| Diabetes Mellitus |
5.4% |
| Prophylaxis |
4.0% |
| Cerebrovascular Accident Prophylaxis |
3.7% |
| Hyperlipidaemia |
2.8% |
| Cardiovascular Disorder |
2.5% |
| Essential Hypertension |
2.0% |
| Blood Cholesterol Increased |
1.7% |
| Cardiac Failure |
1.6% |
| Gastritis |
1.6% |
| Asthma |
1.5% |
| Insomnia |
1.5% |
| Depression |
1.3% |
| Angina Pectoris |
1.3% |
| Hypothyroidism |
1.2% |
| Cerebral Infarction |
1.1% |
| Constipation |
1.1% |
| Atrial Fibrillation |
1.0% |
| Type 2 Diabetes Mellitus |
0.9% |
| Anxiety |
0.9% |
|
| Cerebral Infarction |
11.9% |
| Death |
8.9% |
| Renal Failure |
6.6% |
| Interstitial Lung Disease |
6.3% |
| Cardiac Failure |
5.4% |
| Hypoglycaemia |
5.3% |
| Renal Failure Chronic |
5.0% |
| Drug Ineffective |
4.9% |
| Renal Failure Acute |
4.9% |
| Pneumonia |
4.7% |
| Dizziness |
4.0% |
| Myocardial Infarction |
4.0% |
| Headache |
3.9% |
| Sudden Death |
3.7% |
| Oedema Peripheral |
3.6% |
| Hyperkalaemia |
3.5% |
| Rash |
3.5% |
| Syncope |
3.4% |
| Loss Of Consciousness |
3.3% |
| Hypertension |
3.2% |
|
| Secondary |
| Hypertension |
36.5% |
| Cerebrovascular Accident Prophylaxis |
11.7% |
| Drug Use For Unknown Indication |
9.7% |
| Product Used For Unknown Indication |
6.1% |
| Cardiovascular Disorder |
5.6% |
| Diabetes Mellitus |
4.6% |
| Rheumatoid Arthritis |
3.2% |
| Myocardial Infarction |
2.8% |
| Type 2 Diabetes Mellitus |
2.6% |
| Depression |
2.4% |
| Hyperlipidaemia |
2.2% |
| Prophylaxis |
2.1% |
| Angina Pectoris |
1.9% |
| Atrial Fibrillation |
1.5% |
| Insomnia |
1.4% |
| Pain |
1.2% |
| Cardiac Failure |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Essential Hypertension |
1.2% |
|
| Renal Failure |
16.8% |
| Renal Failure Acute |
9.8% |
| Syncope |
6.9% |
| Renal Impairment |
5.1% |
| Rhabdomyolysis |
5.1% |
| Hepatitis Acute |
4.5% |
| Interstitial Lung Disease |
4.3% |
| Liver Disorder |
4.3% |
| Pneumonia |
4.3% |
| Renal Failure Chronic |
4.3% |
| Hypotension |
4.0% |
| Loss Of Consciousness |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
3.7% |
| Cerebral Infarction |
3.5% |
| Hyperkalaemia |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Pancytopenia |
3.2% |
| Maculopathy |
2.9% |
| Dehydration |
2.7% |
|
| Concomitant |
| Hypertension |
24.8% |
| Product Used For Unknown Indication |
20.0% |
| Drug Use For Unknown Indication |
12.0% |
| Rheumatoid Arthritis |
6.2% |
| Diabetes Mellitus |
5.9% |
| Prophylaxis |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Osteoporosis |
2.6% |
| Pain |
2.5% |
| Atrial Fibrillation |
2.4% |
| Insomnia |
2.1% |
| Depression |
2.0% |
| Blood Cholesterol Increased |
1.9% |
| Asthma |
1.8% |
| Constipation |
1.8% |
| Hepatitis C |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Gastritis |
1.6% |
| Hyperlipidaemia |
1.5% |
| Hypercholesterolaemia |
1.5% |
|
| Vomiting |
10.8% |
| Weight Increased |
6.5% |
| Nausea |
6.3% |
| Weight Decreased |
6.2% |
| Pyrexia |
6.0% |
| Pneumonia |
5.5% |
| Drug Ineffective |
5.3% |
| Renal Failure Acute |
5.2% |
| Renal Impairment |
5.2% |
| Myocardial Infarction |
4.8% |
| Renal Failure |
4.4% |
| Interstitial Lung Disease |
4.3% |
| Rash |
4.2% |
| Rhabdomyolysis |
4.0% |
| White Blood Cell Count Decreased |
3.8% |
| Death |
3.8% |
| Pruritus |
3.5% |
| Platelet Count Decreased |
3.4% |
| Thrombocytopenia |
3.4% |
| Vision Blurred |
3.4% |
|
| Interacting |
| Hypertension |
43.2% |
| Drug Use For Unknown Indication |
9.7% |
| Constipation |
7.7% |
| Cerebrovascular Accident |
3.9% |
| Hyperuricaemia |
3.9% |
| Cardiac Failure |
2.6% |
| Depression |
2.6% |
| Hypothyroidism |
2.6% |
| Ischaemic Heart Disease Prophylaxis |
2.6% |
| Osteoporosis |
2.6% |
| Pain |
2.6% |
| Renal Failure Chronic |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Bladder Disorder |
1.9% |
| Erectile Dysfunction |
1.9% |
| Hepatic Cirrhosis |
1.9% |
| Antiplatelet Therapy |
1.3% |
| Atrial Fibrillation |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Renal Failure Acute |
19.4% |
| Drug Interaction |
12.9% |
| Renal Artery Stenosis |
12.9% |
| Vision Blurred |
9.7% |
| Hyperkalaemia |
6.5% |
| Pulmonary Fibrosis |
6.5% |
| Vomiting |
6.5% |
| Bone Graft |
3.2% |
| Dehydration |
3.2% |
| Electrocardiogram Qrs Complex Prolonged |
3.2% |
| Hypotension |
3.2% |
| Pollakiuria |
3.2% |
| Post Procedural Complication |
3.2% |
| Urinary Hesitation |
3.2% |
| Weight Increased |
3.2% |
|
